Latest Period
Q2 2026
Security Snapshot
Arcutis Biotherapeutics, Inc. - Common Stock, $0.001 par value per share (ARQT) Institutional Ownership
CUSIP: 03969K108
13F Institutional Holders and Ownership History from Q1 2020 to Q2 2026
Institutions Reporting
271
Shares (Excl. Options)
131,310,354
Price
$26.22
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.001 par value per share
- Symbol
- ARQT on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 131,310,354
- Total 13F value
- $3,443,010,431
- Portfolio coverage rank
- 0%
- Share change
- -207,032
- Value change
- +$1,586,900
- Number of holders
- 271
- Shares outstanding
- 125,131,534
- SEC-reported price per share
- $28.42
- Insider filing price
- $28.42
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ARQT - Arcutis Biotherapeutics, Inc. - Common Stock, $0.001 par value per share is tracked under CUSIP 03969K108.
- 271 institutions reported positions in Q2 2026.
- 6 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 269 to 271 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $3,118,364,705 to $3,443,010,431.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 271 institutions filings for Q2 2026.
Security key
03969K108
Latest holder period
Q2 2026
13F holders
271
13D/G owners
6
CIK / CUSIP context first
Open Q2 2026 holders
ARQT full holder history
Arcutis Biotherapeutics, Inc. SEC filings
Arcutis Biotherapeutics, Inc. company facts
Arcutis Biotherapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03969K108:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
6
Security
ARQT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Frazier Life Sciences VIII, L.P. | 7.5% | $130,399,321 | 8,943,712 | Patrick J. Heron | 18 Aug 2025 | |||
| Rubric Capital Management LP | 6.8% | $239,875,733 | 8,271,577 | Rubric Capital Management LP | 31 Dec 2025 | |||
| Polar Capital Holdings Plc | 5.3% | +27% | $173,234,098 | +$41,964,402 | 6,606,945 | +32% | Polar Capital Holdings Plc | 30 Jun 2026 |
| STATE STREET CORP | 4.7% | -8% | $152,674,865 | -$12,411,421 | 5,822,840 | -7.5% | STATE STREET CORPORATION | 30 Jun 2026 |
| PRUDENTIAL FINANCIAL INC | 4.3% | -23% | $127,901,438 | -$42,866,378 | 5,302,713 | -25% | PRUDENTIAL FINANCIAL INC | 31 Mar 2026 |
| JENNISON ASSOCIATES LLC | 4% | -25% | $120,136,172 | -$42,866,932 | 4,980,770 | -26% | Jennison Associates LLC | 31 Mar 2026 |
As of 30 Jun 2026, 271 institutional investors reported holding 131,310,354 shares of Arcutis Biotherapeutics, Inc. - Common Stock, $0.001 par value per share (ARQT). This represents 105% of the company’s total 125,131,534 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
80%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MONTANOVA CAPITAL, LLC | 9.9% | 12,437,000 | +0.89% | 6.9% | $326,098,140 |
| BlackRock, Inc. | 8.4% | 10,545,466 | +15% | 0% | $276,502,120 |
| Frazier Life Sciences Management, L.P. | 7.9% | 9,874,511 | 0% | 5.6% | $258,909,678 |
| Rubric Capital Management LP | 6.6% | 8,271,577 | 0% | 2% | $216,880,749 |
| Polar Capital Holdings Plc | 5.3% | 6,606,945 | +17% | 0.49% | $173,234,098 |
| STATE STREET CORP | 4.7% | 5,822,840 | -7.5% | 0% | $152,674,865 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4% | 4,988,756 | +2.4% | 0% | $130,805,182 |
| MORGAN STANLEY | 3.6% | 4,451,014 | +5.5% | 0.01% | $116,705,607 |
| JENNISON ASSOCIATES LLC | 3.4% | 4,219,058 | -15% | 0.07% | $110,623,703 |
| D. E. Shaw & Co., Inc. | 3.2% | 3,949,609 | +58% | 0.06% | $103,558,748 |
| UBS Group AG | 2.7% | 3,333,015 | +0.11% | 0.01% | $87,391,654 |
| BANK OF AMERICA CORP /DE/ | 2.4% | 2,987,431 | +34% | 0.01% | $78,330,441 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.4% | 2,982,446 | -2.1% | 0% | $78,214,092 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.9% | 2,429,005 | +24% | 0% | $63,688,511 |
| ORBIMED ADVISORS LLC | 1.6% | 2,042,000 | 1% | $53,541,240 | |
| FRANKLIN RESOURCES INC | 1.5% | 1,930,982 | -16% | 0.01% | $50,630,354 |
| AMERICAN CENTURY COMPANIES INC | 1.5% | 1,925,031 | +32% | 0.02% | $50,474,363 |
| GOLDMAN SACHS GROUP INC | 1.3% | 1,668,367 | +4.1% | 0% | $43,744,582 |
| Jupiter Topco LLC | 1.1% | 1,410,435 | 0% | 0.02% | $36,988,658 |
| OBERWEIS ASSET MANAGEMENT INC/ | 1.1% | 1,372,941 | +0.51% | 0.74% | $35,998,513 |
| GILDER GAGNON HOWE & CO LLC | 1% | 1,313,211 | -69% | 0.36% | $34,432,392 |
| GW&K Investment Management, LLC | 1% | 1,288,018 | +30% | 0.26% | $33,772,000 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1% | 1,265,283 | -6.7% | 11% | $33,175,720 |
| BAMCO INC /NY/ | 1% | 1,253,120 | +17% | 0.05% | $32,856,806 |
| CITADEL ADVISORS LLC | 0.93% | 1,160,014 | +7333% | 0.02% | $30,415,567 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
26
Latest
Q2 2026
Rows shown
1-25 of 26
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 131,310,354 | $3,443,010,431 | +$1,586,900 | $26.22 | 271 |
| 2026 Q1 | 132,368,934 | $3,118,364,705 | +$53,160,279 | $23.56 | 269 |
| 2025 Q4 | 128,962,296 | $3,744,475,286 | +$103,845,955 | $29.04 | 280 |
| 2025 Q3 | 125,804,940 | $2,370,184,094 | -$12,772,142 | $18.85 | 235 |
| 2025 Q2 | 127,080,415 | $1,781,069,063 | +$21,637,125 | $14.02 | 228 |
| 2025 Q1 | 125,020,441 | $1,954,466,256 | -$63,284,061 | $15.64 | 239 |
| 2024 Q4 | 128,710,441 | $1,792,934,402 | +$13,789,213 | $13.93 | 206 |
| 2024 Q3 | 128,641,664 | $1,198,282,493 | +$15,921,001 | $9.30 | 187 |
| 2024 Q2 | 126,503,507 | $1,176,619,915 | +$9,242,287 | $9.30 | 184 |
| 2024 Q1 | 124,986,945 | $1,238,517,575 | +$285,414,998 | $9.91 | 166 |
| 2023 Q4 | 101,272,913 | $327,119,655 | +$79,248,549 | $3.23 | 130 |
| 2023 Q3 | 67,159,664 | $356,705,615 | -$26,597,323 | $5.31 | 131 |
| 2023 Q2 | 71,766,867 | $683,988,878 | -$5,745,956 | $9.53 | 135 |
| 2023 Q1 | 71,600,840 | $787,595,702 | +$44,255,428 | $11.00 | 141 |
| 2022 Q4 | 65,632,382 | $971,340,873 | +$87,400,990 | $14.80 | 138 |
| 2022 Q3 | 59,389,299 | $1,134,920,691 | +$194,978,652 | $19.11 | 138 |
| 2022 Q2 | 49,075,739 | $1,045,833,934 | +$17,642,019 | $21.31 | 112 |
| 2022 Q1 | 48,307,139 | $929,780,885 | -$136,426,148 | $19.26 | 106 |
| 2021 Q4 | 46,348,278 | $961,255,152 | -$1,852,441 | $20.74 | 89 |
| 2021 Q3 | 45,697,453 | $1,091,410,573 | +$4,816,184 | $23.89 | 103 |
| 2021 Q2 | 45,474,760 | $1,240,848,739 | -$38,040,013 | $27.29 | 100 |
| 2021 Q1 | 46,841,365 | $1,354,985,371 | +$170,660,745 | $28.93 | 93 |
| 2020 Q4 | 40,973,719 | $1,152,598,120 | +$138,537,380 | $28.13 | 78 |
| 2020 Q3 | 34,766,158 | $1,018,651,387 | +$28,894,471 | $29.30 | 62 |
| 2020 Q2 | 33,776,828 | $1,021,408,758 | +$33,104,690 | $30.24 | 55 |